The leaders behind the standard.

Dr. Brill is Board Certified in Internal Medicine and Gastroenterology. Dr. Brill has run risk-bearing Independent Practice Associations and Physician-Hospital Organizations in California and Arizona, held management positions with and participates on committees for several managed care companies. He was the Medical Director for the BFCC.NCC-QIO oversight project during the 12th SOW, serves on the Editorial Advisory Board for several journals, and was the co-founder of the AGA Center for GI Innovation and Technology.

Dr. Brill works extensively with the Centers for Medicare and Medicaid Services (CMS) and the American Medical Association (AMA) on coding, coverage and reimbursement issues, and co-Chaired the Part D medication measures Technical Expert Panel for CMS. He participates in the CPT Editorial Panel and the AMA RBRVS Update Committee (RUC) and has introduced over 250 HCPCS and CPT coding proposals. He has published extensively on episode and bundled payment methodologies and has developed and submitted advanced payment models to the HHS Physician Focused Payment Model Technical Advisory Committee. He is a consultant to Fogarty Innovation and an external advisor to the FDA's Total Product Lifecycle Advisory Program (TAP).

Dr. Brill was previously an Assistant Clinical Professor of Medicine at the University of Arizona College of Medicine, an Adjunct Assistant Professor of Medicine at Midwestern University, and lectured at the School of Health Management & Policy at the WP Carey School of Business at Arizona State University.

In addition to her industry roles, Kim served as a managing partner at Argenta Advisors and as an independent consultant, always with a focus on patient access. She holds a master's degree in healthcare policy from the University of California, Berkeley.

Brian represents multiple clients on Medicare coverage and payment requirements and policies, providing counsel on the development and implementation of strategic legal and advocacy initiatives in response to congressional and administrative coverage and reimbursement changes.

Through Brian's work, clients have obtained new and expanded Medicare coverage via Local Coverage Determinations, defended against Medicare payment cuts via legislative and regulatory changes, and obtained Medicare payment increases across multiple Medicare payment systems. Before joining Alston & Bird, Brian was a Consultant at the Lewin Group where he served as a CMS contractor advising on Medicare policies that impact multiple payment systems and as one of the lead evaluators of the Bundled Payments for Care Improvement Initiative.

Brian received his JD from the University of Maryland Francis King Carey School of Law and his MPH from the Harvard T.H. Chan School of Public Health.

Keely's strategic collaborations with key stakeholders—including HHS, CMS, the AMA CPT Editorial Panel, physician specialty societies, patient advocacy groups, and international coalitions—have helped shape favorable coverage, policy, and patient access across diverse therapeutic areas. Keely is an FDA TAP collaborator, the FDA program designed to expedite patient access to innovative medical devices; a Panel Judge for MedTech Innovator, the largest accelerator in the world; and, is an Executive member of the NEST, a Collaborative Community comprised of representatives from across the medical device ecosystem.

Keely holds a Masters of Jurisprudence in Health Law from Loyola University, Chicago and a Bachelor of Science degree in Healthcare Administrative Services from Weber State University, Ogden, Utah. She holds the professional designations of Fellow, American College of Healthcare Executives (FACHE), Certified Professional Coder (CPC), Certified Coding Specialist, Physician Based (CCS-P) and Certified in Healthcare Compliance (CHC).

Tonya currently serves as Executive Vice President of Reimbursement, Health Economics, Market Access, and Corporate Development at PRIA Healthcare. As a member of the Executive Leadership Team, she contributes to board-level strategy and leads an integrated platform supporting reimbursement and market access across the product lifecycle. She also plays a key role in corporate development, including mergers and acquisitions, strategic partnerships, and long-term growth planning. During her tenure, PRIA has expanded its service offerings, executed acquisitions, and achieved sustained revenue growth.

Previously, Tonya founded and led the Reimbursement, Health Economics, and Market Access (RHEMA) division at MCRA (acquired by IQVIA), scaling the business across multiple therapeutic areas. She also held leadership roles at Quorum Consulting (acquired by Guidehouse) and Johnson & Johnson, contributing to market access strategy, acquisition evaluation, and global value development.

Throughout her career, Tonya has advised executives, investors, and boards on coverage, coding, payment, pricing, and evidence strategy for emerging medical technologies. She has successfully advanced reimbursement pathways and influenced coverage policy to support adoption of innovative therapies.

She holds a BA in Health Policy Studies from the University of Michigan and an MPH from UCLA.